Array Technologies, Inc. ARRY is expected to witness a decline in its top and bottom lines when it reports fourth-quarter 2025 results. The Zacks Consensus Estimate for ARRY’s fourth-quarter

Appian APPN reported fourth-quarter 2025 non-GAAP earnings of 15 cents per share, surpassing the Zacks Consensus Estimate by 59.57% and decreasing 16.7% year over year.Revenues of $202.9 million

Essex Property Trust’s ESS board of directors has approved a 0.8% hike in the annual cash dividend for its common stock. ESS will now pay out a first-quarter cash dividend of $2.59 per share, up

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

With most Q4 earnings reports now in the rearview mirror, investors are shifting focus toward stocks that delivered strong bottom-line results and positive surprises. However, concentrating solely

Nice NICE reported adjusted earnings of $3.24 per share in the fourth quarter of 2025, which beat the Zacks Consensus Estimate by 0.84% and increased 7% year over year.Non-GAAP revenues of $786.5

GE HealthCare Technologies Inc. GEHC recently announced FDA 510(k) clearance for three new magnetic resonance (MR) innovations — SIGNA Sprint with Freelium, a 1.5T sealed magnet MRI system; SIGNA